THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA

描述(申请人提供)：约三分之一的世界人口感染结核分枝杆菌，世界卫生组织估计，2007年有927万新病例，170多万人死于结核病。结核分枝杆菌能够通过颠覆宿主的固有和适应性防御来建立这种巨大的世界性疾病负担。它做到这一点的一种方法是将巨噬细胞通常不友好的环境转变为它可以有效复制的利基环境。正常情况下，在吞噬小体成熟过程中，细菌空泡从一个相对惰性的隔室转变为一个吞噬溶酶体，一个有效的杀菌和降解隔间。然而，各种分枝杆菌物种阻止吞噬小体的正常成熟，这些吞噬小体居住在一个类似于早期内噬菌体的复制利基中，尽管它们到底是如何做到这一点尚不清楚。我们推测，为了促进其细胞内的生存，结核分枝杆菌分泌EsxH，以抑制运输所需的内体分选复合体(ESCRT)，这是参与蛋白质运输的巨噬细胞的细胞机械。我们发现ESCRT机制代表了细胞的一个主要脆弱性，因为它需要控制非病原体的生长，如耻垢分枝杆菌，以及结核分枝杆菌。此外，我们在结核分枝杆菌蛋白EsxH和宿主蛋白肝细胞生长因子调节的酪氨酸激酶底物(HGS/HRS)之间发现了一种新的宿主-病原体相互作用，HGS/HRS是ESCRT机制的一个组成部分。在这项建议中，我们试图扩展我们的初步研究，以表征ESCRT预防细菌感染的机制。此外，我们还将研究EsxH和HGS之间的相互作用，并评估其对感染结局的重要性。这些研究将为结核分枝杆菌如何颠覆巨噬细胞正常的抗微生物能力提供重要的见解。如果我们了解结核分枝杆菌是如何做到这一点的，我们可能能够提高受感染巨噬细胞的分枝杆菌杀伤力，使新疗法的开发成为可能，这些疗法有可能显著缩短治疗时间，改变全球流行病的面貌。

DESCRIPTION (provided by applicant): Approximately one-third of the world's population is infected with Mycobacterium tuberculosis (M.tb), and the World Health Organization estimates that in 2007 there were 9.27 million new cases and more than 1.7 million people died of tuberculosis. M.tb is able to establish this enormous worldwide burden of disease by subverting innate and adaptive defenses of the host. One way in which it does this is to convert the normally hostile environment of a macrophage into a niche in which it can effectively replicate. Normally during phagosome maturation, the bacterial vacuole is transformed from a comparatively inert compartment to a phagolysosome, an effective microbicidal and degradative compartment. However, a variety of mycobacterial species prevent the normal maturation of the phagosome, residing in a replicative niche that resembles an early endosome, although exactly how they do this is not clear. We hypothesize that to promote its intracellular survival M.tb secrete EsxH in order to inhibit the endosomal sorting complex required for transport (ESCRT), cellular machinery of the macrophage involved in protein trafficking. We found that the ESCRT machinery represents a major vulnerability of the cell, as it is required to control growth of non-pathogens, like Mycobacterium smegmatis, as well as of M.tb. Moreover, we identified a novel host-pathogen interaction between the M.tb protein, EsxH, and the host protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hgs/Hrs), which is a component of the ESCRT machinery. In this proposal, we seek to extend our preliminary studies in order to characterize the mechanism by which ESCRT protects against bacterial infection. In addition, we will investigate the interaction between EsxH and Hgs and evaluate its importance to the outcome of infection. These studies will provide important insight into how M.tb subverts the normal anti-microbial capacity of macrophages. If we understood how M.tb does this, we might be able to improve the mycobacterial killing capacity of the infected macrophage, enabling development of novel therapeutics that have the potential to significantly shorten therapy and change the face of the global epidemic.